|
1
|
Gomceli I, Demiriz B and Tez M: Gastric
carcinogenesis. World J Gastroenterol. 18:5164–5170.
2012.PubMed/NCBI
|
|
2
|
Dong H, Gao Z, Rong H, Jin M and Zhang X:
β-asarone reverses chronic unpredictable mild stress-induced
depression-like behavior and promotes hippocampal neurogenesis in
rats. Molecules. 19:5634–5649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang YX, Chen YT, Zhou XJ, Hong CL, Li CY
and Guo JY: Beta-asarone, a major component of Acorus tatarinowii
Schott, attenuates focal cerebral ischemia induced by middle
cerebral artery occlusion in rats. BMC Complement Altern Med.
13:2362013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu XC, Zhou LG, Liu ZL and Du SS:
Identification of insecticidal constituents of the essential oil of
Acorus calamus rhizomes against Liposcelis bostrychophila Badonnel.
Molecules. 18:5684–5696. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee SH, Kim KY, Ryu SY, Yoon Y, Hahm DH,
Kang SA, Cho SH, Lim JS, Moon EY, Yoon SR, et al: Asarone inhibits
adipogenesis and stimulates lipolysis in 3T3-L1 adipocytes. Cell
Mol Biol (Noisy-le-grand). 56(Suppl): OL1215–OL1222. 2010.
|
|
6
|
Zou X, Liu SL, Zhou JY, Wu J, Ling BF and
Wang RP: Beta-asarone induces LoVo colon cancer cell apoptosis by
up-regulation of caspases through a mitochondrial pathway in vitro
and in vivo. Asian Pac J Cancer Prev. 13:5291–5298. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garg S, Narula J and Chandrashekhar Y:
Apoptosis and heart failure: Clinical relevance and therapeutic
target. J Mol Cell Cardiol. 38:73–79. 2005. View Article : Google Scholar
|
|
8
|
Ghavami S, Hashemi M, Ande SR, Yeganeh B,
Xiao W, Eshraghi M, Bus CJ, Kadkhoda K, Wiechec E, Halayko AJ, et
al: Apoptosis and cancer: Mutations within caspase genes. J Med
Genet. 46:497–510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Majors BS, Betenbaugh MJ and Chiang GG:
Links between metabolism and apoptosis in mammalian cells:
Applications for anti-apoptosis engineering. Metab Eng. 9:317–326.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fan TJ, Han LH, Cong RS and Liang J:
Caspase family proteases and apoptosis. Acta Biochim Biophys Sin
(Shanghai). 7:719–727. 2005. View Article : Google Scholar
|
|
11
|
Autret A and Martin SJ: Emerging role for
members of the Bcl-2 family in mitochondrial morphogenesis. Mol
Cell. 36:355–363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brooks C and Dong Z: Regulation of
mitochondrial morphological dynamics during apoptosis by Bcl-2
family proteins: A key in Bak? Cell Cycle. 6:3043–3047. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghoneum M, Matsuura M, Braga M and
Gollapudi S: S. cerevisiae induces apoptosis in human metastatic
breast cancer cells by altering intracellular Ca2+ and
the ratio of Bax and Bcl-2. Int J Oncol. 33:533–539.
2008.PubMed/NCBI
|
|
14
|
Salakou S, Kardamakis D, Tsamandas AC,
Zolota V, Apostolakis E, Tzelepi V, Papathanasopoulos P, Bonikos
DS, Papapetropoulos T, Petsas T, et al: Increased Bax/Bcl-2 ratio
up-regulates caspase-3 and increases apoptosis in the thymus of
patients with myasthenia gravis. In Vivo. 21:123–132.
2007.PubMed/NCBI
|
|
15
|
Zhang H and Rosdahl I: Bcl-xL and bcl-2
proteins in melanoma progression and UVB-induced apoptosis. Int J
Oncol. 28:661–666. 2006.PubMed/NCBI
|
|
16
|
Acloque H, Thiery JP and Nieto MA: The
physiology and pathology of the EMT. Meeting on the
epithelial-mesenchymal transition. EMBO Rep. 9:322–326. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wells A, Chao YL, Grahovac J, Wu Q and
Lauffenburger DA: Epithelial and mesenchymal phenotypic switchings
modulate cell motility in metastasis. Front Biosci. 16:815–837.
2011. View Article : Google Scholar
|
|
19
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsareva SA, Moriggl R, Corvinus FM,
Wiederanders B, Schütz A, Kovacic B and Friedrich K: Signal
transducer and activator of transcription 3 activation promotes
invasive growth of colon carcinomas through matrix
metalloproteinase induction. Neoplasia. 9:279–291. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Seiler R, Thalmann GN and Fleischmann A:
MMP-2 and MMP-9 in lymph-node-positive bladder cancer. J Clin
Pathol. 64:1078–1082. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Daniele A, Zito AF, Giannelli G, Divella
R, Asselti M, Mazzocca A, Paradiso A and Quaranta M: Expression of
metal-loproteinases MMP-2 and MMP-9 in sentinel lymph node and
serum of patients with metastatic and non-metastatic breast cancer.
Anticancer Res. 30:3521–3527. 2010.PubMed/NCBI
|
|
23
|
Clark JC, Thomas DM, Choong PF and Dass
CR: RECK - a newly discovered inhibitor of metastasis with
prognostic significance in multiple forms of cancer. Cancer
Metastasis Rev. 26:675–683. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Omura A, Matsuzaki T, Mio K, Ogura T,
Yamamoto M, Fujita A, Okawa K, Kitayama H, Takahashi C, Sato C, et
al: RECK forms cowbell-shaped dimers and inhibits matrix
metalloproteinase-catalyzed cleavage of fibronectin. J Biol Chem.
284:3461–3469. 2009. View Article : Google Scholar
|
|
25
|
Takemoto N, Tada M, Hida Y, Asano T, Cheng
S, Kuramae T, Hamada J, Miyamoto M, Kondo S and Moriuchi T: Low
expression of reversion-inducing cysteine-rich protein with Kazal
motifs (RECK) indicates a shorter survival after resection in
patients with adenocarcinoma of the lung. Lung Cancer. 58:376–383.
2007. View Article : Google Scholar : PubMed/NCBI
|
